共存慢性髓性白血病与骨髓纤维化患者的临床特征及全外显子/转录组测序
该研究采用下一代测序分析双重骨髓增殖性肿瘤(MPN)患者的肿瘤细胞,发现多数患者携带TET2、ASXL1/2、SRSF2、IDH2等表观调控基因突变(频率1%-47%),部分患者低频率携带N/KRAS、TP53、BRAF、EZH2、GNAS致癌突变,提示克隆演化;结果支持MPN患者造血细胞存在多种遗传学异常,BCR-ABL获得可能是基因组不稳定所致的继发事件。
要点
- 多数双重MPN患者携带TET2、ASXL1/2、SRSF2、IDH2等克隆性造血相关基因突变,频率1%-47%。
- 部分患者低频率携带N/KRAS、TP53、BRAF、EZH2、GNAS致癌突变,可能代表克隆演化。
- 作者提出BCR-ABL在这些患者中常为基因组不稳定导致的继发事件。
核心结论
- MPN患者造血细胞携带多种遗传学异常,部分可导致克隆优势,JAK2/CALR/MPL突变或BCR-ABL易位可能驱动向特定MPN表型发展。
- 作者提出BCR-ABL在这些患者中的获得常为基因组不稳定所致的继发事件。
研究设计与样本
- 研究采用下一代测序分析双重MPN患者的肿瘤细胞。
- 原文未报告样本量。
主要发现
- 多数双重MPN患者携带TET2、ASXL1/2、SRSF2、IDH2等表观调控基因突变,频率为1%-47%。
- 部分患者低频率携带N/KRAS、TP53、BRAF、EZH2、GNAS致癌突变,可能代表克隆演化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasms (MPNs) are clonal hematopoietic stem cell (HSC) disorders that can be classified on the basis of genetic, clinical, phenotypic features. Genetic lesions such as JAK2 mutations and BCR-ABL translocation are often mutually exclusive in MPN patients and lead to essential thrombocythemia, polycythemia vera, or myelofibrosis or chronic myeloid leukemia, respectively. Nevertheless, coexistence of these genetic aberrations in the same patient has been reported. Whether these aberrations occur in the same stem cell or a different cell is unclear, but an unstable genome in the HSCs seems to be the common antecedent. In an effort to characterize the underlying genetic events that might contribute to the appearance of more than one MPN in a patient, we studied neoplastic cells from patients with dual MPNs by next-generation sequencing. We observed that most patients with two MPNs harbored mutations in genes known to contribute to clonal hematopoiesis through altered epigenetic regulation such as TET2, ASXL1/2, SRSF2, and IDH2 at varying frequencies (1%-47%). In addition, we found that some patients also harbored oncogenic mutations in N/KRAS, TP53, BRAF, EZH2, and GNAS at low frequencies, which probably represent clonal evolution. These findings support the hypothesis that hematopoietic cells from MPN patients harbor multiple genetic aberrations, some of which can contribute to clonal dominance. Acquiring mutations in JAK2/CALR/MPL or the BCR-ABL translocation probably drive the oncogenic phenotype towards a specific MPN. Further, we propose that the acquisition of BCR-ABL in these patients is frequently a secondary event resulting from an unstable genome.
引用
- Kandarpa M, Wu YM, Robinson D, et al. Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis. Am J Hematol. 2017. PMID: 28335073. doi:10.1002/ajh.24728
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。